RQM+, a professional services company with a focus on healthcare, has purchased Jordi Labs for an undisclosed sum. The acquisition will boost RQM+’s regulatory and production services for the medical industry by introducing additional capabilities.
In 2022, Statista’s research indicates that the market for medical technology will generate $575.80 billion in sales. The market’s largest category, medical devices, is estimated to have a market volume of $455.10 billion in 2022 and revenue growth of 5.95% per year through 2027, reaching a market volume of $768.80 billion in that time. This indicates that there is a growing need for consultants who can assist clients make the most of this dynamic industry.
RQM+ is a professional services company having offices in Nottingham, United Kingdom, and Basel, Switzerland, and its main office is in Monroeville, Pennsylvania. According to the company’s LinkedIn profile, it considers itself to be the largest regulatory and clinical consulting organization in the world with a specialization in medical devices and diagnostics. Additionally, it provides a wide range of MedTech services that assist market access for medical devices and diagnostics across the whole product lifecycle.
RQM+ has acquired Jordi Labs as the company seeks to increase its capabilities to meet expanding customer demand across North America and Europe. The Mansfield, Massachusetts-based business offers contaminant and failure investigations, complicated product deformulation, chemical characterization, and failure analysis to MedTech producers.
According to CEO Margaret Keegan, RQM+ is pleased to now provide extended proprietary testing services, giving our customers the quickest road to regulatory clearances. RQM+ is the only MedTech service provider with roots in over 40 years of regulatory strategy.
Mark Jordi, president of Jordi Labs, said, “We are thrilled to now be a part of the RQM+ solution that delivers companies to market faster with our outstanding track record of rapid testing findings that fulfill the strict criteria of regulators worldwide.”
Linden Capital Partners received legal advice from Kirkland and Ellis. Jordi Labs was represented by Harris Williams.
